Ainos, Inc. (NASDAQ:AIMD) Short Interest Up 1,959.7% in January

Ainos, Inc. (NASDAQ:AIMD) was the target of a large increase in short interest in the month of January. As of January 30th, there was short interest totaling 364,031 shares, an increase of 1,959.7% from the January 15th total of 17,674 shares. Approximately 8.4% of the shares of the company are sold short. Based on an average daily volume of 3,475,966 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 3,475,966 shares, the days-to-cover ratio is presently 0.1 days. Approximately 8.4% of the shares of the company are sold short.

Ainos Price Performance

Ainos stock traded down $0.03 during mid-day trading on Tuesday, hitting $1.85. The stock had a trading volume of 41,712 shares, compared to its average volume of 1,418,321. The company has a current ratio of 2.96, a quick ratio of 2.67 and a debt-to-equity ratio of 1.10. Ainos has a one year low of $1.61 and a one year high of $4.50. The firm’s 50 day moving average is $1.98 and its 200 day moving average is $2.81. The firm has a market capitalization of $8.90 million, a P/E ratio of -0.46 and a beta of 2.49.

Ainos (NASDAQ:AIMD) last posted its quarterly earnings results on Thursday, November 13th. The company reported ($0.64) EPS for the quarter. The company had revenue of $0.00 million during the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Ainos in a research report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

Insider Activity at Ainos

In other news, major shareholder Carbon Nano Technology Taiwan sold 46,000 shares of the stock in a transaction that occurred on Wednesday, January 28th. The shares were sold at an average price of $2.17, for a total value of $99,820.00. Following the transaction, the insider owned 989,925 shares in the company, valued at $2,148,137.25. This represents a 4.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Over the last ninety days, insiders have sold 47,281 shares of company stock worth $102,152. 9.79% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Ainos stock. Two Sigma Investments LP bought a new stake in shares of Ainos, Inc. (NASDAQ:AIMD) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 23,008 shares of the company’s stock, valued at approximately $80,000. Two Sigma Investments LP owned about 0.48% of Ainos as of its most recent filing with the Securities & Exchange Commission.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.